Cyclophosphamide
- Product NDC
- 25021-248
- 11-digit product format
- 250210248
- Labeler code
- 25021
- Product ID
- 25021-248_5ed11ef9-73c0-42d1-9cac-0fba10a1f991
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Cyclophosphamide
- Dosage form
- INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
- Route
- INTRAVENOUS
- Labeler
- Sagent Pharmaceuticals
- Application
- ANDA214529
- Marketing category
- ANDA
- Marketing start
- 2024-01-15
- Substance
- CYCLOPHOSPHAMIDE
- Active strength
- 1 g/50mL
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Cyclophosphamide
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| CYCLOPHOSPHAMIDE | 1 g/50mL |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | 8N3DW7272P |
| Rxcui | 1734917, 1734919, 1734921 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 25021-248-51 | Cyclophosphamide | 1 in 1 CARTON | INJECTION, POWDER, LYOPHILIZED, | 1 | | 4 |
| 25021-248-51 | Cyclophosphamide | 50 mL in 1 VIAL | INJECTION, POWDER, LYOPHILIZED, | 50 | | 4 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 25021-248 | CYCLOPHOSPHAMIDE INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [SAGENT PHARMACEUTICALS] | 4 | Current NDC, 2 package rows | 20250304_329b5a3a-c7b9-4b11-abf0-009719cdfb79.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|
| 25021-248-51 | 25021024851 | 1 VIAL in 1 CARTON (25021-248-51) / 50 mL in 1 VIAL | 1 vial | 2024-01-15 | No | No | Current |